Table 2.
Summary of transient kinetic results for human M2β-S1 exchanged with K104E versus WT RLC
Rate/equilibrium constants (± SE)WTK104E
ATP binding (actomyosin)a, n = 3   
K’1Tk’+2T (µM–1·s–17.7 ± 0.1 7.6 ± 0.3 
K0.5 (µM) 174 ± 60 62 ± 14 
k’+2T (s–11,527 ± 358 636 ± 76 
Actomyosin ADP release (pyrene)a, n = 4   
k’+D (s–1242.5 ± 17.2 284.4 ± 9.9 
Actomyosin mantADP releaseb, n = 4   
k’+D (s–1196.5 ± 15.6 157.1 ± 5.8 
Rate/equilibrium constants (± SE)WTK104E
ATP binding (actomyosin)a, n = 3   
K’1Tk’+2T (µM–1·s–17.7 ± 0.1 7.6 ± 0.3 
K0.5 (µM) 174 ± 60 62 ± 14 
k’+2T (s–11,527 ± 358 636 ± 76 
Actomyosin ADP release (pyrene)a, n = 4   
k’+D (s–1242.5 ± 17.2 284.4 ± 9.9 
Actomyosin mantADP releaseb, n = 4   
k’+D (s–1196.5 ± 15.6 157.1 ± 5.8 

k’+2T, maximal rate of ATP-induced dissociation; K’1Tk’+2T, second-order rate constant for ATP binding. K0.5’, ATP concentration at which the observed rate constant is one-half maximal.

a

Pyrene actin fluorescence.

b

mantADP fluorescence.

or Create an Account

Close Modal
Close Modal